Faina Gurevich, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 350 Budfield St, Johnstown, PA 15904 Phone: 814-266-9919 |
Varun Malhotra, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 350 Budfield St, Johnstown, PA 15904 Phone: 412-788-4995 Fax: 412-788-0250 |
Dr. Sunil Kumar Soi, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 350 Budfield Street, Johnstown, PA 15904 Phone: 814-266-9919 Fax: 814-266-0499 |
Anton Y Verbine, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 350 Budfield St, Johnstown, PA 15904 Phone: 814-266-9919 Fax: 814-266-0499 |
Suneeta Gadde, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 350 Budfield St, Suite A, Johnstown, PA 15904 Phone: 814-266-9919 Fax: 814-266-0499 |
News Archive
The weight-loss industry is finding itself in the crosshairs of the Federal Trade Commission's "Operation Big Fat Lies" - a crackdown on slimming down pills, powders and patches that are too good to be true. The Center for Consumer Freedom (CCF) recommends that grossly exaggerated statistics and hype from pharmaceutical and weight-loss companies about the nation's so-called "obesity epidemic" also be placed under the federal microscope.
Adolescent girls receiving a wide range of medical care in the Emergency Department (ED) are receptive to receiving information about preventing pregnancy, according to the results of a cross-sectional survey published online July 11 in the Journal of Pediatrics.
Obese adolescents are more likely than their normal-weight counterparts to have hearing loss, according to results of a new study. Findings showed that obese adolescents had increased hearing loss across all frequencies and were almost twice as likely to have unilateral (one-sided) low-frequency hearing loss.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
› Verified 7 days ago